Investor Fights Illumina's Poison Pill Against Roche Bid

Law360, New York (March 7, 2012, 8:00 PM EST) -- Gene-sequencing firm Illumina Inc. was hit Tuesday with a proposed shareholder class action intended as an antidote to the company's recent poison pill efforts to resist a hostile takeover by Roche Holding AG.

The complaint in California federal court seeks to compel Illumina’s board to negotiate a sale, saying company leaders breached their fiduciary duty by rejecting a $5.7 billion bid from Roche and pursuing a defensive scheme to make a takeover unfeasible.

Under the poison pill plan, if Roche or another bidder gains control of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Derfler v. Illumina, Inc. et al


Case Number

3:12-cv-00564

Court

California Southern

Nature of Suit

Securities/Commodities

Judge

Roger T. Benitez

Date Filed

March 5, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.